Search research articles
Contact Us
Filters
Showing results (91-100 of 215) with videos related to
Page
of 22
Sort By:
Haemostasis
|
July 27, 1999
Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study
M L Bots, M M Breteler, F van Kooten, et al.
ESMO Real World Data and Digital Oncology
|
April 3, 2026
Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer
J Bosveld, B B M Suelmann, M J Bijlsma, et al.
European Urology Open Science
|
May 15, 2023
Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies?
Siberyn T Nuijens, Lisa M C van Hoogstraten, Richard P Meijer, et al.
Industrial & Engineering Chemistry Research
|
April 28, 2025
Effect of Tertiary Amine Selection on CO<sub>2</sub> to Formic Acid Hydrogenation with the Au-np Catalyst
Anouk W N de Leeuw den Bouter, Luca M P Meijer, Larissa Brito, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 1, 1996
Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris
M P de Maat, A C de Bart, B C Hennis, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
March 17, 2023
The prevalence and intensity of late effects in patients with testicular germ cell tumors: A first step of instrument development using a stepwise approach
Roos Enzlin, Sigrid C J M Vervoort, Britt B M Suelmann, et al.
Urologic Oncology
|
October 28, 2025
Molecular subtyping of advanced bladder cancer patients and patient-derived organoids based on a 3-marker immunohistochemistry approach to evaluate chemotherapy sensitivity
Bastiaan J Viergever, Alba C Zuidema, Trudy Jonges, et al.
The Journal of Experimental Medicine
|
November 12, 2003
The B cell antigen receptor controls integrin activity through Btk and PLCgamma2
Marcel Spaargaren, Esther A Beuling, Mette L Rurup, et al.
The Journal of Urology
|
August 21, 2012
Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?
Laura S Mertens, Richard P Meijer, J Martijn Kerst, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 2, 2009
Biological variation in inflammatory and hemostatic markers
G Rudez, P Meijer, H M H Spronk, et al.
Page
of 22
Search research articles
Search
Showing results (91-100 of 215) with videos related to
Sort By:
Page
of 22
Haemostasis
|
July 27, 1999
Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study
M L Bots, M M Breteler, F van Kooten, et al.
ESMO Real World Data and Digital Oncology
|
April 3, 2026
Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer
J Bosveld, B B M Suelmann, M J Bijlsma, et al.
European Urology Open Science
|
May 15, 2023
Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies?
Siberyn T Nuijens, Lisa M C van Hoogstraten, Richard P Meijer, et al.
Industrial & Engineering Chemistry Research
|
April 28, 2025
Effect of Tertiary Amine Selection on CO<sub>2</sub> to Formic Acid Hydrogenation with the Au-np Catalyst
Anouk W N de Leeuw den Bouter, Luca M P Meijer, Larissa Brito, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 1, 1996
Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris
M P de Maat, A C de Bart, B C Hennis, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
|
March 17, 2023
The prevalence and intensity of late effects in patients with testicular germ cell tumors: A first step of instrument development using a stepwise approach
Roos Enzlin, Sigrid C J M Vervoort, Britt B M Suelmann, et al.
Urologic Oncology
|
October 28, 2025
Molecular subtyping of advanced bladder cancer patients and patient-derived organoids based on a 3-marker immunohistochemistry approach to evaluate chemotherapy sensitivity
Bastiaan J Viergever, Alba C Zuidema, Trudy Jonges, et al.
The Journal of Experimental Medicine
|
November 12, 2003
The B cell antigen receptor controls integrin activity through Btk and PLCgamma2
Marcel Spaargaren, Esther A Beuling, Mette L Rurup, et al.
The Journal of Urology
|
August 21, 2012
Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?
Laura S Mertens, Richard P Meijer, J Martijn Kerst, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 2, 2009
Biological variation in inflammatory and hemostatic markers
G Rudez, P Meijer, H M H Spronk, et al.
Page
of 22